No Data
No Data
Birdman ETC [Stocks with interesting features seen from Volume changes]
Closing price and changes from the previous day Volume * <7063> Birdman 2,316,718,200 * <149A> Shinka 1,074,150,153,700 * <3238> Central General 4,791,138,800 * <1560> Bursa KLCI 5,180,301,068 * <9561> Glad Cube 89,126,375,200 * <9791> Biken Tech 1,012,653,1900 * <8707> Iwai Koss Corp 256,049,353,200 * <9658> Bizi Tai Show 269,314,162,800
Individual stock information.
Kei Pharma <4896.T> is under a stop-high buy order. Keio University School of Medicine, which conducts joint research with the company, announced new research findings on regenerative medicine targeting subacute spinal cord injuries, one of the candidates in the development pipeline for regenerative medicine, on the weekend of the 21st. In the clinical study of regenerative medicine using iPS cell-derived neural progenitor cells, improvements were observed in two out of four patients. Saifuse <4892.T> Tokyo Stock Exchange is utilizing Margin Trading.
Requio Pharmaceuticals, GDH and others.
＜3133＞ Kaifan Birdman has signed a business consignment contract with ＜7063＞. ＜4169＞ Enechange recorded a subsidy benefit of 0.041 billion yen as non-operating income. ＜4437＞ GDH has increased the Dividends, with a year-end distribution of 4.00 yen per share, up from 3.00 yen. ＜4475＞ HENGGE has established a joint venture (consolidated subsidiary) in the USA. ＜4579＞ Raquoia Pharmaceutical has entered into a capital and business partnership agreement with HK inno.N Corporation (South Korea), through the issuance of new shares via third-party allotment (2.59 million).
Express News | [Change Report] Akihiro Date reported a decrease in shareholding of Birdman (7063.JP) to 6.59%.
Express News | 【Change Report】YourTurn reported a decrease in Shareholding percentage of Birdman (7063.JP) to 24.48%.
Express News | [Change Report] Akihiro Date reported a reduction in Shareholding in Birdman (7063.JP) to 7.6%.